Matthias Imöhl

2.0k total citations
55 papers, 1.5k citations indexed

About

Matthias Imöhl is a scholar working on Epidemiology, Microbiology and Infectious Diseases. According to data from OpenAlex, Matthias Imöhl has authored 55 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Epidemiology, 19 papers in Microbiology and 17 papers in Infectious Diseases. Recurrent topics in Matthias Imöhl's work include Pneumonia and Respiratory Infections (29 papers), Bacterial Infections and Vaccines (19 papers) and Pneumocystis jirovecii pneumonia detection and treatment (14 papers). Matthias Imöhl is often cited by papers focused on Pneumonia and Respiratory Infections (29 papers), Bacterial Infections and Vaccines (19 papers) and Pneumocystis jirovecii pneumonia detection and treatment (14 papers). Matthias Imöhl collaborates with scholars based in Germany, France and Austria. Matthias Imöhl's co-authors include Mark van der Linden, Stephanie Perniciaro, Ralf René Reinert, Alexander Krüttgen, Gerhard Falkenhorst, Christian Cornélissen, Michael Dreher, Mathias W. Hornef, Michael Kleines and Michael Kleines and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Journal of Clinical Microbiology.

In The Last Decade

Matthias Imöhl

54 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthias Imöhl Germany 24 843 450 366 219 144 55 1.5k
George Zahariadis Canada 16 718 0.9× 468 1.0× 128 0.3× 73 0.3× 42 0.3× 46 1.4k
Eun Young Cho South Korea 17 468 0.6× 220 0.5× 231 0.6× 96 0.4× 21 0.1× 78 976
G. Le Moal France 20 594 0.7× 803 1.8× 110 0.3× 166 0.8× 20 0.1× 68 1.6k
Britta Gröndahl Germany 14 572 0.7× 282 0.6× 97 0.3× 48 0.2× 32 0.2× 22 796
Markus A. Rose Germany 26 582 0.7× 178 0.4× 188 0.5× 87 0.4× 22 0.2× 76 1.6k
F.A.I. Riordan United Kingdom 17 324 0.4× 233 0.5× 244 0.7× 289 1.3× 10 0.1× 45 898
Patricia M. Roblin United States 24 713 0.8× 166 0.4× 733 2.0× 157 0.7× 21 0.1× 64 1.4k
Kevin Katz Canada 15 478 0.6× 723 1.6× 19 0.1× 158 0.7× 43 0.3× 50 1.4k
Md. Ahsanul Haq Bangladesh 16 109 0.1× 348 0.8× 42 0.1× 41 0.2× 73 0.5× 65 748

Countries citing papers authored by Matthias Imöhl

Since Specialization
Citations

This map shows the geographic impact of Matthias Imöhl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Imöhl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Imöhl more than expected).

Fields of papers citing papers by Matthias Imöhl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthias Imöhl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Imöhl. The network helps show where Matthias Imöhl may publish in the future.

Co-authorship network of co-authors of Matthias Imöhl

This figure shows the co-authorship network connecting the top 25 collaborators of Matthias Imöhl. A scholar is included among the top collaborators of Matthias Imöhl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthias Imöhl. Matthias Imöhl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Krüttgen, Alexander, et al.. (2023). Humoral immune response to SARS-CoV-2 mRNA vaccines is associated with choice of vaccine and systemic adverse reactions DMD TNR. Clinical and Experimental Vaccine Research. 12(1). 60–60. 1 indexed citations
2.
Krüttgen, Alexander, et al.. (2021). Evaluation of the QuantiFERON SARS-CoV-2 interferon-ɣ release assay in mRNA-1273 vaccinated health care workers. Journal of Virological Methods. 298. 114295–114295. 25 indexed citations
3.
Imöhl, Matthias, Stephanie Perniciaro, Andreas Busse, & Mark van der Linden. (2021). Bacterial Spectrum of Spontaneously Ruptured Otitis Media in a 7-Year, Longitudinal, Multicenter, Epidemiological Cross-Sectional Study in Germany. Frontiers in Medicine. 8. 675225–675225. 15 indexed citations
4.
Rose, Markus A., et al.. (2021). Nasopharyngeal Carriage in Children After the Introduction of Generalized Infant Pneumococcal Conjugate Vaccine Immunization in Germany. Frontiers in Medicine. 8. 719481–719481. 16 indexed citations
5.
Krüttgen, Alexander, et al.. (2021). Two novel SARS-CoV-2 surrogate virus neutralization assays are suitable for assessing successful immunization with mRNA-1273. Journal of Virological Methods. 299. 114297–114297. 22 indexed citations
6.
Linden, Mark van der, Matthias Imöhl, & Stephanie Perniciaro. (2019). Limited indirect effects of an infant pneumococcal vaccination program in an aging population. PLoS ONE. 14(8). e0220453–e0220453. 63 indexed citations
7.
Evliyaoğlu, Osman, Josef van Helden, Matthias Imöhl, & Ralf Weiskirchen. (2018). Vitamin B1 interpretation: Erroneous higher levels in non-anemic populations. Nutrition. 60. 25–29. 2 indexed citations
8.
Imöhl, Matthias, Christina Fitzner, Stephanie Perniciaro, & Mark van der Linden. (2017). Epidemiology and distribution of 10 superantigens among invasive Streptococcus pyogenes disease in Germany from 2009 to 2014. PLoS ONE. 12(7). e0180757–e0180757. 34 indexed citations
9.
Schmitz, Julia, Mark van der Linden, Adnan Al‐Lahham, et al.. (2017). Fluoroquinolone resistance in Streptococcus pneumoniae isolates in Germany from 2004–2005 to 2014–2015. International Journal of Medical Microbiology. 307(4-5). 216–222. 14 indexed citations
10.
Linden, Mark van der, Gerhard Falkenhorst, Stephanie Perniciaro, Christina Fitzner, & Matthias Imöhl. (2016). Effectiveness of Pneumococcal Conjugate Vaccines (PCV7 and PCV13) against Invasive Pneumococcal Disease among Children under Two Years of Age in Germany. PLoS ONE. 11(8). e0161257–e0161257. 57 indexed citations
11.
Linden, Mark van der, Gerhard Falkenhorst, Stephanie Perniciaro, & Matthias Imöhl. (2015). Effects of Infant Pneumococcal Conjugate Vaccination on Serotype Distribution in Invasive Pneumococcal Disease among Children and Adults in Germany. PLoS ONE. 10(7). e0131494–e0131494. 96 indexed citations
12.
Imöhl, Matthias, Ralf René Reinert, & Mark van der Linden. (2015). Antibiotic susceptibility rates of invasive pneumococci before and after the introduction of pneumococcal conjugate vaccination in Germany. International Journal of Medical Microbiology. 305(7). 776–783. 19 indexed citations
13.
Linden, Mark van der, Stephanie Perniciaro, & Matthias Imöhl. (2015). Increase of serotypes 15A and 23B in IPD in Germany in the PCV13 vaccination era. BMC Infectious Diseases. 15(1). 207–207. 77 indexed citations
14.
Linden, Mark van der, Matthias Imöhl, Andreas Busse, Markus A. Rose, & Dieter Adam. (2014). Bacterial spectrum of spontaneously ruptured otitis media in the era of pneumococcal conjugate vaccination in Germany. European Journal of Pediatrics. 174(3). 355–364. 26 indexed citations
15.
Imöhl, Matthias, Ralf René Reinert, Paul M. Tulkens, & Mark van der Linden. (2014). Penicillin susceptibility breakpoints for Streptococcus pneumoniae and their effect on susceptibility categorisation in Germany (1997–2013). European Journal of Clinical Microbiology & Infectious Diseases. 33(11). 2035–2040. 10 indexed citations
16.
17.
Imöhl, Matthias, Mark van der Linden, Ralf René Reinert, & Klaus Ritter. (2011). Invasive group A streptococcal disease and association with varicella in Germany, 1996–2009. FEMS Immunology & Medical Microbiology. 62(1). 101–109. 26 indexed citations
18.
Imöhl, Matthias, et al.. (2010). Serotype distribution of invasive pneumococcal disease during the first 60 days of life. Vaccine. 28(30). 4758–4762. 9 indexed citations
19.
Imöhl, Matthias, Ralf René Reinert, & Mark van der Linden. (2009). New penicillin susceptibility breakpoints for Streptococcus pneumoniae and their effects on susceptibility categorisation in Germany (1992–2008). International Journal of Antimicrobial Agents. 34(3). 271–273. 17 indexed citations
20.
Wilhelm, Michael, Jürgen Wittsiepe, Friederike Lemm, et al.. (2007). The Duisburg birth cohort study: Influence of the prenatal exposure to PCDD/Fs and dioxin-like PCBs on thyroid hormone status in newborns and neurodevelopment of infants until the age of 24 months. Mutation Research/Reviews in Mutation Research. 659(1-2). 83–92. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by George Zahariadis Breakdown of academic impact, for papers by Eun Young Cho Breakdown of academic impact, for papers by G. Le Moal Breakdown of academic impact, for papers by Britta Gröndahl Breakdown of academic impact, for papers by Markus A. Rose Breakdown of academic impact, for papers by F.A.I. Riordan Breakdown of academic impact, for papers by Patricia M. Roblin Breakdown of academic impact, for papers by Kevin Katz Breakdown of academic impact, for papers by Md. Ahsanul Haq
Rankless by CCL
2026